Popular prescription acne medication discontinued in Canada
Summary
- Bausch Health has discontinued the commercialization of Retin-A Tretinoin Cream 0.05% & Gel 0.025% in Canada for business reasons unrelated to safety or quality.
- Existing inventory of the discontinued products will remain available until approximately March or until stock is depleted.
- Pharmacist Alexandre Mihaila describes the medications as affordable vitamin A derivatives used for acne & cosmetic purposes, noting that finding replacements involves risks of new side effects.
- Experts warn that alternative tretinoin formulations & similar medications may be considerably more expensive, with some newer options costing over $100 compared to the discontinued products' roughly $40 price point.
- Professor Mina Tadrous urges patients against stockpiling the medication & reassures them that other effective treatments remain available.
- Sarah Larose from Dalhousie University notes that other medications in the same class exist & may be less irritating, advising patients to consult pharmacists regarding coverage & availability.
- Tadrous expresses concern that these discontinuations create a frustrating & difficult journey for patients navigating an already stretched healthcare system.
A popular prescription acne treatment has been discontinued in Canada, leaving patients to choose from more expensive alternatives.